BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: James MH, Mahler SV, Moorman DE, Aston-Jones G. A Decade of Orexin/Hypocretin and Addiction: Where Are We Now? Curr Top Behav Neurosci 2017;33:247-81. [PMID: 28012090 DOI: 10.1007/7854_2016_57] [Cited by in Crossref: 80] [Cited by in F6Publishing: 76] [Article Influence: 16.0] [Reference Citation Analysis]
Number Citing Articles
1 Boss C, Roch C. Orexin research: patent news from 2016. Expert Opinion on Therapeutic Patents 2017;27:1123-33. [DOI: 10.1080/13543776.2017.1344221] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
2 Kourosh-arami M, Gholami M, Alavi-kakhki SS, Komaki A. Neural correlates and potential targets for the contribution of orexin to addiction in cortical and subcortical areas. Neuropeptides 2022. [DOI: 10.1016/j.npep.2022.102259] [Reference Citation Analysis]
3 Alijanpour S, Khakpai F, Ebrahimi-ghiri M, Zarrindast M. Co-administration of the low dose of orexin and nitrergic antagonists induces an antidepressant-like effect in mice. Biomedicine & Pharmacotherapy 2019;109:589-94. [DOI: 10.1016/j.biopha.2018.10.033] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
4 Yaeger JD, Krupp KT, Gale JJ, Summers CH. Counterbalanced microcircuits for Orx1 and Orx2 regulation of stress reactivity. Medicine in Drug Discovery 2020;8:100059. [DOI: 10.1016/j.medidd.2020.100059] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Nazari S, Pourmand SM, Makki SM, Brand S, Vousooghi N. Potential biomarkers of addiction identified by real-time PCR in human peripheral blood lymphocytes: a narrative review. Biomark Med 2022;16:739-58. [PMID: 35658670 DOI: 10.2217/bmm-2021-0291] [Reference Citation Analysis]
6 Chieffi S, Carotenuto M, Monda V, Valenzano A, Villano I, Precenzano F, Tafuri D, Salerno M, Filippi N, Nuccio F, Ruberto M, De Luca V, Cipolloni L, Cibelli G, Mollica MP, Iacono D, Nigro E, Monda M, Messina G, Messina A. Orexin System: The Key for a Healthy Life. Front Physiol 2017;8:357. [PMID: 28620314 DOI: 10.3389/fphys.2017.00357] [Cited by in Crossref: 68] [Cited by in F6Publishing: 62] [Article Influence: 13.6] [Reference Citation Analysis]
7 Subramanian S, Ravichandran M. Orexin receptors: Targets and applications. Fundam Clin Pharmacol 2021. [PMID: 34464995 DOI: 10.1111/fcp.12723] [Reference Citation Analysis]
8 Kalló I, Omrani A, Meye FJ, de Jong H, Liposits Z, Adan RAH. Characterization of orexin input to dopamine neurons of the ventral tegmental area projecting to the medial prefrontal cortex and shell of nucleus accumbens. Brain Struct Funct 2022. [PMID: 35029758 DOI: 10.1007/s00429-021-02449-8] [Reference Citation Analysis]
9 Wiskerke J, James MH, Aston-Jones G. The orexin-1 receptor antagonist SB-334867 reduces motivation, but not inhibitory control, in a rat stop signal task. Brain Res 2020;1731:146222. [PMID: 31002819 DOI: 10.1016/j.brainres.2019.04.017] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
10 Mohammadkhani A, Fragale JE, Pantazis CB, Bowrey HE, James MH, Aston-Jones G. Orexin-1 Receptor Signaling in Ventral Pallidum Regulates Motivation for the Opioid Remifentanil. J Neurosci 2019;39:9831-40. [PMID: 31641055 DOI: 10.1523/JNEUROSCI.0255-19.2019] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 5.3] [Reference Citation Analysis]
11 Arrigoni E, Chee MJS, Fuller PM. To eat or to sleep: That is a lateral hypothalamic question. Neuropharmacology 2019;154:34-49. [PMID: 30503993 DOI: 10.1016/j.neuropharm.2018.11.017] [Cited by in Crossref: 49] [Cited by in F6Publishing: 39] [Article Influence: 12.3] [Reference Citation Analysis]
12 Freeman LR, Aston-Jones G. Activation of medial hypothalamic orexin neurons during a Go/No-Go task. Brain Res 2020;1731:145928. [PMID: 30176242 DOI: 10.1016/j.brainres.2018.08.031] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
13 Pan JS, Zheng K, Liu JH, Gao ZY, Ye YG, Ye MJ, Tang W, Liu LJ, Zhu C. Orexin might Predict Status of Alcohol Dependence. Chin Med J (Engl) 2018;131:2866-7. [PMID: 30511692 DOI: 10.4103/0366-6999.246068] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
14 Farrell MR, Schoch H, Mahler SV. Modeling cocaine relapse in rodents: Behavioral considerations and circuit mechanisms. Prog Neuropsychopharmacol Biol Psychiatry 2018;87:33-47. [PMID: 29305936 DOI: 10.1016/j.pnpbp.2018.01.002] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 9.8] [Reference Citation Analysis]
15 James MH, Fragale JE, Aurora RN, Cooperman NA, Langleben DD, Aston-Jones G. Repurposing the dual orexin receptor antagonist suvorexant for the treatment of opioid use disorder: why sleep on this any longer? Neuropsychopharmacology 2020;45:717-9. [PMID: 31986520 DOI: 10.1038/s41386-020-0619-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 7.0] [Reference Citation Analysis]
16 Matzeu A, Kallupi M, George O, Schweitzer P, Martin-Fardon R. Dynorphin Counteracts Orexin in the Paraventricular Nucleus of the Thalamus: Cellular and Behavioral Evidence. Neuropsychopharmacology 2018;43:1010-20. [PMID: 29052613 DOI: 10.1038/npp.2017.250] [Cited by in Crossref: 23] [Cited by in F6Publishing: 25] [Article Influence: 4.6] [Reference Citation Analysis]
17 Esmaili-Shahzade-Ali-Akbari P, Hosseinzadeh H, Mehri S. Effect of suvorexant on morphine tolerance and dependence in mice: Role of NMDA, AMPA, ERK and CREB proteins. Neurotoxicology 2021;84:64-72. [PMID: 33609567 DOI: 10.1016/j.neuro.2021.02.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
18 Stanojlovic M, Pallais JP, Lee MK, Kotz CM. Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease. Mol Brain 2019;12:87. [PMID: 31666100 DOI: 10.1186/s13041-019-0514-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pantazis CB, James MH, Bentzley BS, Aston-Jones G. The number of lateral hypothalamus orexin/hypocretin neurons contributes to individual differences in cocaine demand. Addict Biol 2020;25:e12795. [PMID: 31297913 DOI: 10.1111/adb.12795] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 10.5] [Reference Citation Analysis]
20 Lei K, Kwok C, Darevsky D, Wegner SA, Yu J, Nakayama L, Pedrozo V, Anderson L, Ghotra S, Fouad M, Hopf FW. Nucleus Accumbens Shell Orexin-1 Receptors Are Critical Mediators of Binge Intake in Excessive-Drinking Individuals. Front Neurosci 2019;13:88. [PMID: 30814925 DOI: 10.3389/fnins.2019.00088] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
21 Simmons SJ, Gentile TA. Cocaine abuse and midbrain circuits: Functional anatomy of hypocretin/orexin transmission and therapeutic prospect. Brain Res 2020;1731:146164. [PMID: 30796894 DOI: 10.1016/j.brainres.2019.02.026] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
22 Demidova A, Kahl E, Fendt M. Orexin deficiency affects sensorimotor gating and its amphetamine-induced impairment. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2022. [DOI: 10.1016/j.pnpbp.2022.110517] [Reference Citation Analysis]
23 Daiwile AP, Jayanthi S, Cadet JL. Sex differences in methamphetamine use disorder perused from pre-clinical and clinical studies: Potential therapeutic impacts. Neurosci Biobehav Rev 2022;137:104674. [PMID: 35452744 DOI: 10.1016/j.neubiorev.2022.104674] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Collier AD, Halkina V, Min SS, Roberts MY, Campbell SD, Camidge K, Leibowitz SF. Embryonic Ethanol Exposure Affects the Early Development, Migration, and Location of Hypocretin/Orexin Neurons in Zebrafish. Alcohol Clin Exp Res 2019;43:1702-13. [PMID: 31206717 DOI: 10.1111/acer.14126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
25 Fragale JE, Pantazis CB, James MH, Aston-Jones G. The role of orexin-1 receptor signaling in demand for the opioid fentanyl. Neuropsychopharmacology 2019;44:1690-7. [PMID: 31112988 DOI: 10.1038/s41386-019-0420-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
26 Saad L, Zwiller J, Kalsbeek A, Anglard P. Epigenetic Regulation of Circadian Clocks and Its Involvement in Drug Addiction. Genes (Basel) 2021;12:1263. [PMID: 34440437 DOI: 10.3390/genes12081263] [Reference Citation Analysis]
27 Summers CH, Yaeger JDW, Staton CD, Arendt DH, Summers TR. Orexin/hypocretin receptor modulation of anxiolytic and antidepressive responses during social stress and decision-making: Potential for therapy. Brain Res 2020;1731:146085. [PMID: 30590027 DOI: 10.1016/j.brainres.2018.12.036] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
28 Neu P, Sofin Y, Danker-Hopfe H. The Effect of Detoxification on Sleep: How Does Sleep Quality Change during Qualified Detoxification Treatment? J Addict 2018;2018:9492453. [PMID: 30671277 DOI: 10.1155/2018/9492453] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
29 McGinn MA, Pantazis CB, Tunstall BJ, Marchette RCN, Carlson ER, Said N, Koob GF, Vendruscolo LF. Drug addiction co-morbidity with alcohol: Neurobiological insights. Int Rev Neurobiol 2021;157:409-72. [PMID: 33648675 DOI: 10.1016/bs.irn.2020.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 Luca G, Peris L. Sleep Quality and Sleep Disturbance Perception in Dual Disorder Patients. J Clin Med 2020;9:E2015. [PMID: 32604951 DOI: 10.3390/jcm9062015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
31 James MH, McNally GP, Li X. Editorial: Role of the Thalamus in Motivated Behavior. Front Behav Neurosci 2021;15:720592. [PMID: 34276320 DOI: 10.3389/fnbeh.2021.720592] [Reference Citation Analysis]
32 Moorman DE. The hypocretin/orexin system as a target for excessive motivation in alcohol use disorders. Psychopharmacology (Berl) 2018;235:1663-80. [PMID: 29508004 DOI: 10.1007/s00213-018-4871-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]
33 Turku A, Leino TO, Karhu L, Yli-Kauhaluoma J, Kukkonen JP, Wallén EAA, Xhaard H. Structure-Activity Relationships of 1-Benzoylazulenes at the OX1 and OX2 Orexin Receptors. ChemMedChem 2019;14:965-81. [PMID: 30892823 DOI: 10.1002/cmdc.201900074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
34 al'Absi M, Lemieux A, Hodges JS, Allen S. Circulating orexin changes during withdrawal are associated with nicotine craving and risk for smoking relapse. Addict Biol 2019;24:743-53. [PMID: 30117237 DOI: 10.1111/adb.12643] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
35 Castro DC, Bruchas MR. A Motivational and Neuropeptidergic Hub: Anatomical and Functional Diversity within the Nucleus Accumbens Shell. Neuron 2019;102:529-52. [PMID: 31071288 DOI: 10.1016/j.neuron.2019.03.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 45] [Article Influence: 17.7] [Reference Citation Analysis]
36 Juárez-Portilla C, Pitter M, Kim RD, Patel PY, Ledesma RA, LeSauter J, Silver R. Brain Activity during Methamphetamine Anticipation in a Non-Invasive Self-Administration Paradigm in Mice. eNeuro 2018;5:ENEURO. [PMID: 29632871 DOI: 10.1523/ENEURO.0433-17.2018] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
37 Valentino RJ, Volkow ND. Drugs, sleep, and the addicted brain. Neuropsychopharmacology 2020;45:3-5. [PMID: 31311031 DOI: 10.1038/s41386-019-0465-x] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]
38 Mehr JB, Bilotti MM, James MH. Orexin (hypocretin) and addiction. Trends Neurosci 2021;44:852-5. [PMID: 34642086 DOI: 10.1016/j.tins.2021.09.002] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
39 Bjorness TE, Greene RW. Sleep Deprivation Enhances Cocaine Conditioned Place Preference in an Orexin Receptor-Modulated Manner. eNeuro 2020;7:ENEURO. [PMID: 33139319 DOI: 10.1523/ENEURO.0283-20.2020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Hopf FW. Recent perspectives on orexin/hypocretin promotion of addiction-related behaviors. Neuropharmacology 2020;168:108013. [PMID: 32092435 DOI: 10.1016/j.neuropharm.2020.108013] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]
41 Simmons SJ, Martorana R, Philogene-Khalid H, Tran FH, Gentile TA, Xu X, Su S, Rawls SM, Muschamp JW. Role of hypocretin/orexin receptor blockade on drug-taking and ultrasonic vocalizations (USVs) associated with low-effort self-administration of cathinone-derived 3,4-methylenedioxypyrovalerone (MDPV) in rats. Psychopharmacology (Berl) 2017;234:3207-15. [PMID: 28786030 DOI: 10.1007/s00213-017-4709-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.6] [Reference Citation Analysis]
42 Stanojlovic M, Pallais JP, Kotz CM. Chemogenetic Modulation of Orexin Neurons Reverses Changes in Anxiety and Locomotor Activity in the A53T Mouse Model of Parkinson's Disease. Front Neurosci 2019;13:702. [PMID: 31417337 DOI: 10.3389/fnins.2019.00702] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
43 Kaplan GB, Lakis GA, Zhoba H. Sleep-Wake and Arousal Dysfunctions in Post-Traumatic Stress Disorder:Role of Orexin Systems. Brain Res Bull 2022:S0361-9230(22)00121-6. [PMID: 35618150 DOI: 10.1016/j.brainresbull.2022.05.006] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Chang GQ, Karatayev O, Boorgu DSSK, Leibowitz SF. CCL2/CCR2 Chemokine System in Embryonic Hypothalamus: Involvement in Sexually Dimorphic Stimulatory Effects of Prenatal Ethanol Exposure on Peptide-Expressing Neurons. Neuroscience 2020;424:155-71. [PMID: 31705896 DOI: 10.1016/j.neuroscience.2019.10.013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
45 Choi MR, Cho H, Chun JW, Yoo JH, Kim DJ. Increase of orexin A in the peripheral blood of adolescents with Internet gaming disorder. J Behav Addict 2020;9:93-104. [PMID: 31957460 DOI: 10.1556/2006.8.2019.65] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Freeman LR, Bentzley BS, James MH, Aston-Jones G. Sex Differences in Demand for Highly Palatable Foods: Role of the Orexin System. Int J Neuropsychopharmacol 2021;24:54-63. [PMID: 32496559 DOI: 10.1093/ijnp/pyaa040] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
47 Tsai MC, Huang TL. Orexin A in men with heroin use disorder undergoing methadone maintenance treatment. Psychiatry Res 2018;264:412-5. [PMID: 29680730 DOI: 10.1016/j.psychres.2018.04.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
48 James MH, Aston-Jones G. Orexin/Hypocretin, Central Amygdala, and Escalation of Cocaine Intake. Biol Psychiatry 2017;81:552-3. [PMID: 28283054 DOI: 10.1016/j.biopsych.2017.01.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
49 Katzman MA, Katzman MP. Neurobiology of the Orexin System and Its Potential Role in the Regulation of Hedonic Tone. Brain Sciences 2022;12:150. [DOI: 10.3390/brainsci12020150] [Reference Citation Analysis]
50 Saad L, Sartori M, Pol Bodetto S, Romieu P, Kalsbeek A, Zwiller J, Anglard P. Regulation of Brain DNA Methylation Factors and of the Orexinergic System by Cocaine and Food Self-Administration. Mol Neurobiol 2019;56:5315-31. [DOI: 10.1007/s12035-018-1453-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
51 Fragale JE, James MH, Aston-Jones G. Intermittent self-administration of fentanyl induces a multifaceted addiction state associated with persistent changes in the orexin system. Addict Biol 2021;26:e12946. [PMID: 32798290 DOI: 10.1111/adb.12946] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 11.0] [Reference Citation Analysis]
52 James MH, Stopper CM, Zimmer BA, Koll NE, Bowrey HE, Aston-Jones G. Increased Number and Activity of a Lateral Subpopulation of Hypothalamic Orexin/Hypocretin Neurons Underlies the Expression of an Addicted State in Rats. Biol Psychiatry 2019;85:925-35. [PMID: 30219208 DOI: 10.1016/j.biopsych.2018.07.022] [Cited by in Crossref: 47] [Cited by in F6Publishing: 56] [Article Influence: 11.8] [Reference Citation Analysis]
53 Brown RM, Dayas CV, James MH, Smith RJ. New directions in modelling dysregulated reward seeking for food and drugs. Neurosci Biobehav Rev 2021:S0149-7634(21)00485-1. [PMID: 34736883 DOI: 10.1016/j.neubiorev.2021.10.043] [Reference Citation Analysis]
54 Rouault AA, Lee AA, Sebag JA. Regions of MRAP2 required for the inhibition of orexin and prokineticin receptor signaling. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2017;1864:2322-9. [DOI: 10.1016/j.bbamcr.2017.09.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 5.2] [Reference Citation Analysis]
55 Walker LC. A balancing act: the role of pro- and anti-stress peptides within the central amygdala in anxiety and alcohol use disorders. J Neurochem 2021;157:1615-43. [PMID: 33450069 DOI: 10.1111/jnc.15301] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
56 Tavakkolifard M, Vousooghi N, Mahboubi S, Golab F, Ejtemaei Mehr S, Zarrindast MR. Evaluation of the relationship between the gene expression level of orexin-1 receptor in the rat blood and prefrontal cortex, novelty-seeking, and proneness to methamphetamine dependence: A candidate biomarker. Peptides 2020;131:170368. [PMID: 32668268 DOI: 10.1016/j.peptides.2020.170368] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
57 Pulver A, Kiive E, Kanarik M, Harro J. Association of orexin/hypocretin receptor gene (HCRTR1) with reward sensitivity, and interaction with gender. Brain Res 2020;1746:147013. [PMID: 32652147 DOI: 10.1016/j.brainres.2020.147013] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
58 Suchting R, Yoon JH, Miguel GGS, Green CE, Weaver MF, Vincent JN, Fries GR, Schmitz JM, Lane SD. Preliminary examination of the orexin system on relapse-related factors in cocaine use disorder. Brain Res 2020;1731:146359. [PMID: 31374218 DOI: 10.1016/j.brainres.2019.146359] [Cited by in Crossref: 9] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
59 Anderson RI, Moorman DE, Becker HC. Contribution of Dynorphin and Orexin Neuropeptide Systems to the Motivational Effects of Alcohol. Handb Exp Pharmacol 2018;248:473-503. [PMID: 29526023 DOI: 10.1007/164_2018_100] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
60 Daiwile AP, Jayanthi S, Cadet JL. Sex- and Brain Region-specific Changes in Gene Expression in Male and Female Rats as Consequences of Methamphetamine Self-administration and Abstinence. Neuroscience 2021;452:265-79. [PMID: 33242543 DOI: 10.1016/j.neuroscience.2020.11.025] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
61 Zlebnik NE, Holtz NA, Lepak VC, Saykao AT, Zhang Y, Carroll ME. Age-specific treatment effects of orexin/hypocretin-receptor antagonism on methamphetamine-seeking behavior. Drug Alcohol Depend 2021;224:108719. [PMID: 33940327 DOI: 10.1016/j.drugalcdep.2021.108719] [Reference Citation Analysis]
62 Daiwile AP, Jayanthi S, Ladenheim B, McCoy MT, Brannock C, Schroeder J, Cadet JL. Sex Differences in Escalated Methamphetamine Self-Administration and Altered Gene Expression Associated With Incubation of Methamphetamine Seeking. Int J Neuropsychopharmacol 2019;22:710-23. [PMID: 31562746 DOI: 10.1093/ijnp/pyz050] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 8.0] [Reference Citation Analysis]
63 Collier AD, Yasmin N, Khalizova N, Campbell S, Onoichenco A, Fam M, Albeg AS, Leibowitz SF. Sexually dimorphic and asymmetric effects of embryonic ethanol exposure on hypocretin/orexin neurons as related to behavioral changes in zebrafish. Sci Rep 2021;11:16078. [PMID: 34373563 DOI: 10.1038/s41598-021-95707-y] [Reference Citation Analysis]
64 Pantazis CB, James MH, O'Connor S, Shin N, Aston-Jones G. Orexin-1 receptor signaling in ventral tegmental area mediates cue-driven demand for cocaine. Neuropsychopharmacology 2021. [PMID: 34635803 DOI: 10.1038/s41386-021-01173-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
65 James MH, Fragale JE, O'Connor SL, Zimmer BA, Aston-Jones G. The orexin (hypocretin) neuropeptide system is a target for novel therapeutics to treat cocaine use disorder with alcohol coabuse. Neuropharmacology 2021;183:108359. [PMID: 33091458 DOI: 10.1016/j.neuropharm.2020.108359] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
66 Zhou K, Zhu Y. The paraventricular thalamic nucleus: A key hub of neural circuits underlying drug addiction. Pharmacol Res 2019;142:70-6. [PMID: 30772461 DOI: 10.1016/j.phrs.2019.02.014] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 5.3] [Reference Citation Analysis]
67 Barson JR. Orexin/hypocretin and dysregulated eating: Promotion of foraging behavior. Brain Res 2020;1731:145915. [PMID: 30125533 DOI: 10.1016/j.brainres.2018.08.018] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
68 [DOI: 10.1101/2020.04.25.061887] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
69 Berrendero F, Flores Á, Robledo P. When orexins meet cannabinoids: Bidirectional functional interactions. Biochemical Pharmacology 2018;157:43-50. [DOI: 10.1016/j.bcp.2018.08.040] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
70 Feltenstein MW, See RE, Fuchs RA. Neural Substrates and Circuits of Drug Addiction. Cold Spring Harb Perspect Med 2021;11:a039628. [PMID: 32205414 DOI: 10.1101/cshperspect.a039628] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
71 Fragale JE, James MH, Avila JA, Spaeth AM, Aurora RN, Langleben D, Aston-Jones G. The Insomnia-Addiction Positive Feedback Loop: Role of the Orexin System. Front Neurol Neurosci 2021;45:117-27. [PMID: 34052815 DOI: 10.1159/000514965] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
72 Powers KG, Ma XM, Eipper BA, Mains RE. Identifying roles for peptidergic signaling in mice. Proc Natl Acad Sci U S A 2019;116:20169-79. [PMID: 31455734 DOI: 10.1073/pnas.1910495116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
73 Czora-poczwardowska K, Kujawski R, Słyńko-krzyżostaniak J, Mikołajczak PŁ, Szulc M. Orexin receptor blockers: A tool for lowering alcohol intake and alcohol addictive behavior in the light of preclinical studies. Postępy Higieny i Medycyny Doświadczalnej 2021;75:959-69. [DOI: 10.2478/ahem-2021-0007] [Reference Citation Analysis]
74 Choudhary AG, Somalwar AR, Sagarkar S, Rale A, Sakharkar A, Subhedar NK, Kokare DM. CART neurons in the lateral hypothalamus communicate with the nucleus accumbens shell via glutamatergic neurons in paraventricular thalamic nucleus to modulate reward behavior. Brain Struct Funct 2018;223:1313-28. [PMID: 29116427 DOI: 10.1007/s00429-017-1544-6] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
75 James MH, Bowrey HE, Stopper CM, Aston-Jones G. Demand elasticity predicts addiction endophenotypes and the therapeutic efficacy of an orexin/hypocretin-1 receptor antagonist in rats. Eur J Neurosci 2019;50:2602-12. [PMID: 30240516 DOI: 10.1111/ejn.14166] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
76 García-García F, Priego-Fernández S, López-Muciño LA, Acosta-Hernández ME, Peña-Escudero C. Increased alcohol consumption in sleep-restricted rats is mediated by delta FosB induction. Alcohol 2021;93:63-70. [PMID: 33662520 DOI: 10.1016/j.alcohol.2021.02.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
77 Zhang D, Perrey DA, Decker AM, Langston TL, Mavanji V, Harris DL, Kotz CM, Zhang Y. Discovery of Arylsulfonamides as Dual Orexin Receptor Agonists. J Med Chem 2021;64:8806-25. [PMID: 34101446 DOI: 10.1021/acs.jmedchem.1c00841] [Reference Citation Analysis]
78 Douton JE, Augusto C, Stoltzfus B, Carkaci-Salli N, Vrana KE, Grigson PS. Glucagon-like peptide-1 receptor agonist, exendin-4, reduces reinstatement of heroin-seeking behavior in rats. Behav Pharmacol 2021;32:265-77. [PMID: 33229892 DOI: 10.1097/FBP.0000000000000609] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
79 McGregor R, Thannickal TC, Siegel JM. Pleasure, addiction, and hypocretin (orexin). Handb Clin Neurol 2021;180:359-74. [PMID: 34225941 DOI: 10.1016/B978-0-12-820107-7.00022-7] [Reference Citation Analysis]
80 Matzeu A, Martin-Fardon R. Targeting the Orexin System for Prescription Opioid Use Disorder. Brain Sci 2020;10:E226. [PMID: 32290110 DOI: 10.3390/brainsci10040226] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
81 Staton CD, Yaeger JDW, Khalid D, Haroun F, Fernandez BS, Fernandez JS, Summers BK, Summers TR, Sathyanesan M, Newton SS, Summers CH. Orexin 2 receptor stimulation enhances resilience, while orexin 2 inhibition promotes susceptibility, to social stress, anxiety and depression. Neuropharmacology 2018;143:79-94. [PMID: 30240784 DOI: 10.1016/j.neuropharm.2018.09.016] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 5.8] [Reference Citation Analysis]
82 Alonso-Caraballo Y, Guha SK, Chartoff EH. The neurobiology of abstinence-induced reward-seeking in males and females. Pharmacol Biochem Behav 2021;200:173088. [PMID: 33333134 DOI: 10.1016/j.pbb.2020.173088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
83 James MH, Aston-Jones G. Introduction to the Special Issue: "Making orexin-based therapies for addiction a reality: What are the steps from here?". Brain Res 2020;1731:146665. [PMID: 31930996 DOI: 10.1016/j.brainres.2020.146665] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
84 Yeoh JW, James MH, Adams CD, Bains JS, Sakurai T, Aston-Jones G, Graham BA, Dayas CV. Activation of lateral hypothalamic group III metabotropic glutamate receptors suppresses cocaine-seeking following abstinence and normalizes drug-associated increases in excitatory drive to orexin/hypocretin cells. Neuropharmacology 2019;154:22-33. [PMID: 30253175 DOI: 10.1016/j.neuropharm.2018.09.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
85 Berro LF, Moreira-Junior EDC, Rowlett JK. The dual orexin receptor antagonist almorexant blocks the sleep-disrupting and daytime stimulant effects of methamphetamine in rhesus monkeys. Drug Alcohol Depend 2021;227:108930. [PMID: 34358767 DOI: 10.1016/j.drugalcdep.2021.108930] [Reference Citation Analysis]
86 Shankar A, Williams CT. The darkness and the light: diurnal rodent models for seasonal affective disorder. Dis Model Mech 2021;14:dmm047217. [PMID: 33735098 DOI: 10.1242/dmm.047217] [Reference Citation Analysis]
87 Zarrabian S, Riahi E, Karimi S, Razavi Y, Haghparast A. The potential role of the orexin reward system in future treatments for opioid drug abuse. Brain Research 2020;1731:146028. [DOI: 10.1016/j.brainres.2018.11.023] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
88 Mohammadkhani A, James MH, Pantazis CB, Aston-Jones G. Persistent effects of the orexin-1 receptor antagonist SB-334867 on motivation for the fast acting opioid remifentanil. Brain Res 2020;1731:146461. [PMID: 31526801 DOI: 10.1016/j.brainres.2019.146461] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 3.7] [Reference Citation Analysis]